Kirkland's And 2 Other Stocks Under $3 Insiders Are Buying
Portfolio Pulse from Lisa Levin
Insiders at Kirkland's, Inc. (KIRK), Vivani Medical, Inc. (VANI), and Lixte Biotechnology Holdings, Inc. (LIXT) have recently purchased shares in their respective companies. This comes after Kirkland's reported weaker-than-expected Q2 FY23 results, Vivani Medical posted a wider-than-expected Q2 loss, and Lixte Biotechnology's stock fell around 73% over the past six months.
October 06, 2023 | 12:59 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Kirkland's President and COO Amy E. Sullivan acquired 2,847 shares at an average price of $1.76, following weaker-than-expected Q2 FY23 results.
Insider buying, especially from high-ranking executives, often signals confidence in the company's future prospects. Despite weaker-than-expected Q2 FY23 results, this purchase could indicate a positive outlook.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Lixte Biotechnology's President and CEO Bastiaan van der Baan acquired 10,000 shares at an average price of $2.80, after the company's stock fell around 73% over the past six months.
The purchase of shares by Lixte Biotechnology's CEO, despite a significant stock price drop, could indicate confidence in the company's potential to rebound.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Vivani Medical's Director Gregg Williams acquired 9,924 shares at an average price of $1.00, following a wider-than-expected Q2 loss.
Despite a wider-than-expected Q2 loss, the insider purchase by Vivani Medical's Director could suggest a belief in the company's recovery and future growth.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100